JPRN-UMIN000031513已完成未知
Optimal regimens of sulfamethoxazole-trimethoprim for prophylaxis of pneumocystis pneumonia in patients with systemic rheumatic diseases: multi-center randomized open label trial - Optimal regimens of Baktar for prophylaxis of pneumocystis pneumonia in patients with systemic rheumatic diseases
Juntendo University School of Medicin0 个研究点目标入组 89 人开始时间: 2018年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 89
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Have contraindications to SMX/TMP 2.Have a history of PCP 3.Have received biologic agents 4.Have uncontrollable complications 5.Body weight below 40 kg 6.Being pregnant or a nursing woman 7.Being unable to start SMX/TMP within 14 days of starting prednisolone 8.Unable to give informed consent
研究者
相似试验
已完成
不适用
Cotrimoxazol to prevent malaria in HIV-infected pregnant women in Sub-Saharan AfricaISRCTN98835811AlterSanté (France)300
已完成
不适用
Single dose combination of sulfametoxazole/trimethoprim after percutaneous endoscopic gastrostomyPercutaneous endoscopic gastrostomy procedureSurgeryAttention to artificial openingsISRCTN18677736Karolinska Institutet (Sweden)200
已完成
2 期
A study of role of trimethoprim-sulfamethoxazole in opportunistic infection prevention in lupus patients taking low-level immunosuppressive treatmentTrimethoprim-sulfamethoxazole primary prophylaxis in lupus patients taking low-level immunosuppressive treatmentLupusTrimethoprim-sulfamethoxazolePneumocystis pneumoniaSystemic lupus erythematosusTCTR20230606002Mahidol university138
已完成
不适用
A prospective study of Trimethoprime-sulfamethoxazole(TMP/SMX) for prevention of Pneumocystis pneumonia(PCP) in patients under immunosuppressive therapyThe patients with rheumatic diseases who are receiving more than 30mg/day of prednisoloneJPRN-UMIN000001647Division of Rheumatology,Department of Internal Medicine,Toho University School of Mdicine,Tokyo,Japan60
已完成
4 期
The effects of trimethoprim-sulfamethoxazole on the pharmacokinetic parameters of mycophenolate mofetil in healthy volunteersHealthyHealthy volunteersTCTR20200518005Faculty of Medicine, Chiang Mai University16